Hamedani AG - Search Results

1

Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias.

Lai RY, Rummey C, Amlang CJ, Lin CR, Chen TX, Perlman S, Wilmot G, Gomez CM, Schmahmann JD, Paulson H, Ying SH, Onyike CU, Zesiewicz TA, Bushara KO, Geschwind MD, Figueroa KP, Pulst SM, Subramony SH, Burns MR, Opal P, Duquette A, Ashizawa T, Hamedani AG, Davis MY, Srinivasan SR, Moore LR, Shakkottai VG, Rosenthal LS, Kuo SH. Lai RY, et al. Among authors: hamedani ag. Mov Disord Clin Pract. 2024 May;11(5):496-503. doi: 10.1002/mdc3.14006. Epub 2024 Feb 29. Mov Disord Clin Pract. 2024. PMID: 38419568

2

Migraine and white matter hyperintensities: the ARIC MRI study.

Hamedani AG, Rose KM, Peterlin BL, Mosley TH, Coker LH, Jack CR, Knopman DS, Alonso A, Gottesman RF. Hamedani AG, et al. Neurology. 2013 Oct 8;81(15):1308-13. doi: 10.1212/WNL.0b013e3182a8235b. Epub 2013 Aug 23. Neurology. 2013. PMID: 23975874 Free PMC article.

3

Vision Loss as a Presenting Feature of Chronic Inflammatory Demyelinating Polyneuropathy: A Case Series.

Kruszewski AM, Tauqeer Z, Meer EA, Bautista SA, Cherayil NR, Cimino ME, Khella SL, Lancaster E, Bird SJ, Scherer SS, Revere KE, Hamedani AG, Liu GT, Tamhankar MA. Kruszewski AM, et al. Among authors: hamedani ag. J Neuroophthalmol. 2023 Mar 1;43(1):48-54. doi: 10.1097/WNO.0000000000001700. Epub 2022 Dec 21. J Neuroophthalmol. 2023. PMID: 35921552

4

Longitudinal analysis of contrast acuity in Friedreich ataxia.

Hamedani AG, Hauser LA, Perlman S, Mathews K, Wilmot GR, Zesiewicz T, Subramony SH, Ashizawa T, Delatycki MB, Brocht A, Lynch DR. Hamedani AG, et al. Neurol Genet. 2018 Jul 23;4(4):e250. doi: 10.1212/NXG.0000000000000250. eCollection 2018 Aug. Neurol Genet. 2018. PMID: 30065952 Free PMC article.

5

Prevalence and Risk Factors for Double Vision in Parkinson Disease.

Hamedani AG, Maguire MG, Marras C, Willis AW. Hamedani AG, et al. Mov Disord Clin Pract. 2021 Apr 22;8(5):709-712. doi: 10.1002/mdc3.13220. eCollection 2021 Jul. Mov Disord Clin Pract. 2021. PMID: 34307743 Free PMC article.

6

Visual Impairment Is More Common in Parkinson's Disease and Is a Risk Factor for Poor Health Outcomes.

Hamedani AG, Abraham DS, Maguire MG, Willis AW. Hamedani AG, et al. Mov Disord. 2020 Sep;35(9):1542-1549. doi: 10.1002/mds.28182. Epub 2020 Jul 14. Mov Disord. 2020. PMID: 32662528 Free PMC article.

7

Adjusting for Underrepresentation Reveals Widespread Underestimation of Parkinson's Disease Symptom Burden.

Hamedani AG, Auinger P, Willis AW, Safarpour D, Shprecher D, Stover N, Subramanian T, Cloud L. Hamedani AG, et al. Mov Disord. 2023 Sep;38(9):1679-1687. doi: 10.1002/mds.29507. Epub 2023 Jun 15. Mov Disord. 2023. PMID: 37318322

8

CSF pleocytosis and syndrome of inappropriate antidiuretic hormone secretion in Creutzfeldt-Jakob disease.

Hamedani AG, McLane HC, Kimbaris G, Jacobs DA, Berger JR. Hamedani AG, et al. Neurol Clin Pract. 2016 Aug;6(4):e30-e32. doi: 10.1212/CPJ.0000000000000218. Neurol Clin Pract. 2016. PMID: 29443132 Free PMC article. No abstract available.

9

Self-reported visual dysfunction in Parkinson disease: the Survey of Health, Ageing and Retirement in Europe.

Hamedani AG, Willis AW. Hamedani AG, et al. Eur J Neurol. 2020 Mar;27(3):484-489. doi: 10.1111/ene.14092. Epub 2019 Oct 19. Eur J Neurol. 2020. PMID: 31571317 Free PMC article.

10

Self-reported Visual Difficulty, Age-related Eye Disease, and Neuropsychiatric Outcomes in Older Adults.

Hamedani AG, Willis AW, Ying GS. Hamedani AG, et al. Ophthalmic Epidemiol. 2024 May 8:1-9. doi: 10.1080/09286586.2024.2343725. Online ahead of print. Ophthalmic Epidemiol. 2024. PMID: 38718102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page